Loading
Latest filing published 17 May 2023 for iSpecimen Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Andrew L. Ross is a declared insider of iSpecimen Inc. (board member), with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 17 June 2021 and the latest from 1 January 2023.
On the market, this insider has only ever bought: 1 purchase, €526 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
Most recently, on 17 May 2023, the filings show a share grant in iSpecimen Inc. The most recent open-market purchase was published on 29 November 2021, 1,792 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations